dihexa clinical trials status 2026 International Day 2026: inside First-in-Human trials 5 clinical trials to watch

Proper refrigeration provides the full, recommended shelf life without introducing the catastrophic variable of non-homogenous mixing

Effects of BIM-23627 on GH release in anesthetizedmale rats after short-term high-dose dexamethasone treatment

Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth

It reduces stomach acid production

These findings suggest a possible use of FcRn antagonists as treatments for obesity, which warrants further investigation

This pentadecapeptide demonstrates resistance to degradation in gastric juice, a property that distinguishes it from many therapeutic peptides that require modified administration routes to avoid gastric inactivation